Market Place
Sourcing Support
Supriya Lifescience reports 19% revenue increase in Q2 FY25
01 Nov 2024 //
INDPHARMAPOST
Smallcap Pharma Stock with Strong Financials & Market Performance
29 Oct 2024 //
MARKETMOJO
Remarkable Entrepreneurial Journey of Dr. Satish Wagh in Pharma
25 Oct 2024 //
APNNEWS
AI and Precision Medicine: Transforming Pharma Industry
27 Sep 2024 //
CEOINSIGHTINDIA
Supriya Life Challenges China`s Dominance On Drug Ingredients
20 Sep 2024 //
NDTV
Interview with Shivani, Joint Managing Director, Supriya Lifescience
11 Sep 2024 //
DSIJARTICLE
Supriya Lifescience reports 21.7 per cent Y-o-Y revenue increase in Q1 FY24
13 Aug 2024 //
ECONOMICTIMES
Supriya Lifescience Ltd appoints Dr Saloni Wagh as MD
02 Aug 2024 //
ECONOMICTIMES
Supriya Lifescience promoter Wagh family’s next-gen to helm company
02 Aug 2024 //
THEHINDUBUSINESSLINE
Pharma industry experts eye budget boost for innovation and global ambitions
08 Jul 2024 //
EXPRESS PHARMA
Pharma sector demands substantial R&D incentives, tax relief & IP framework
04 Jul 2024 //
FINANCIAL EXPRESS
Our primary goal is to double our revenue, enter higher-margin niche segments
25 Jun 2024 //
FINANCIAL EXPRESS
Supriya Lifescience FY24 PAT up 32%
03 Jun 2024 //
INDIANPHARMAPOST
Pharma will be a major contributor to India’s economy: Dr Satish Wagh, Chairman
28 Mar 2024 //
FINANCIAL EXPRESS
Supriya Lifesci Standalone March 2024 Net Sales at Rs 158.18 crore
28 Mar 2024 //
MONEY CONTROL
Supriya champions women`s integral role in India`s USD 5 trillion ambition
11 Mar 2024 //
PHARMABIZ
Women`s integral role in India`s US$ 5 trillion ambition
11 Mar 2024 //
INDIANPHARMAPOST
Supriya Lifescience expects to double revenue to Rs 1,000 crore in next 3 years
09 Mar 2024 //
ECONOMICTIMES
Interview | The secret behind the tripling of profit for this Mumbai drug maker
08 Mar 2024 //
CNBC18
In an interaction with Dr Saloni Wagh, Director of Supriya Lifescience Ltd
08 Mar 2024 //
DSIJ
Supriya Life science Wins 8 Gold Awards at Maharashtra State Export Event
13 Feb 2024 //
INDIANPHARMAOUTLOOK
Supriya Lifescience confident of meeting FY24 revenue guidance after strong Q3
12 Feb 2024 //
CNBC18
Supriya Lifesciences Q3 Results: Net profit triples to Rs 30 crore
08 Feb 2024 //
ECONOMICTIMES
Supriya Lifesciences targets Brazil, eyes Rs 200 crore sales in 2-3 years
11 Jan 2024 //
BUSINESS-STANDARD
Supriya Lifescience gets GMP certification from ANVISA Brazil
09 Jan 2024 //
EXPRESS PHARMA
Supriya Lifescience eyes strong growth in Latin America with 10 newly reg APIs
08 Jan 2024 //
CNBC18
Supriya CFO aims for Rs 1,000 crore revenue by FY27, advocates R&D policy
04 Jan 2024 //
ECONOMICTIMES
Supriya Lifescience to bet on R&D, expansion to grow revenues
10 Dec 2023 //
ECONOMICTIMES
Supriya Lifescience and KIIT collaborate on oral cancer detection kit
07 Nov 2023 //
THEHINDUBUSINESSLINE
Supriya Life targets 1-2% global mkt share with oral cancer detection kit
23 Oct 2023 //
BUSINESS-STANDARD
Supriya Lifescience shares rise post tie-up with US-based Plasma Nutrition
03 Aug 2023 //
THEHINDUBUSINESSLINE
Supriya Lifescience collaborates with Plasma Nutrition for protein technology
03 Aug 2023 //
INDINPHARMAPOST
Supriya Lifescience jumps on bargain hunting
16 Feb 2023 //
BUSINESS-STANDARD
Supriya Lifescience Announces Rajeev Kumar Jain as CEO & Key Managerial Personnel
03 Oct 2022 //
PRESS RELEASE
Supriya Life gains on securing CEP for anti-histamine therapy
29 Sep 2022 //
BUSINESS STANDARD
Supriya Lifescience falls 6% on CEO`s resignation
28 Sep 2022 //
ECONOMIC TIMES
Supriya Lifescience Financial Year 2021-2022 Q3
21 Jan 2022 //
PRESS RELEASE
Supriya Lifescience Creating true values that bind global health
21 Jan 2022 //
PRESS RELEASE
Supriya Lifescience gets reality check; Hikal back in demand after 11 sessions
21 Jan 2022 //
ECONOMICTIMES
Un-Audited Financial Results For The Quarter Ended December 31, 2021
01 Jan 2022 //
PRESS RELEASE
Supriya Lifescience IPO subscribed 71.47 times on last day
20 Dec 2021 //
ECONOMICTIMES
Supriya Lifescience IPO fully booked in under 2 hours; should you subscribe
16 Dec 2021 //
FINANCIAL EXPRESS
Supriya Lifescience IPO to open on 16th December
13 Dec 2021 //
EXPRESSPHARMA
Revive Therapeutics Partners with Supriya to Pursue EUA for Bucillamine
08 Jun 2021 //
GLOBENEWSWIRE
Supriya Lifescience files DRHP to raise Rs 1,200 crore via IPO
16 May 2021 //
ECONOMIC TIMES
